Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354003 · ClinicalTrials.gov registry record
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
A clinical trial, sponsored by Institute for Neurodegenerative Disorders.
- Completed
- Registry status
- 800
- Enrollment target
NCT00354003: Completed study, sponsored by Institute for Neurodegenerative Disorders.
NCT00354003 is a clinical trial that has completed, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00354003 has completed, sponsored by Institute for Neurodegenerative Disorders.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and what is the impact of the imaging data information on the management of their symptoms.
Interventions
- BEHAVIORAL A series of questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-08 |
What the finished NCT00354003 record still lists
NCT00354003 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which A series of questionnaires is the first listed.
NCT00354003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00354003 about?
NCT00354003 is a clinical study titled "The Study of the Impact of Disclosing Imaging Study Information to Trial Participants". The overall goal of the study is to evaluate how research participants in Parkinson Disease studies that include brain imaging with a dopamine transporter ligand choose to receive the imaging data and what is the impact of the imaging data information on the management of their symptoms.
What is the current status of trial NCT00354003?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2006-07. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00354003?
The interventions under investigation include: A series of questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00354003?
This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia